AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present Open-Medicine AI Growth Plan, Live Platform Demo in Webinar
Lantern Pharma (NASDAQ: LTRN) will present the growth plan for Open-Medicine AI (“OMAI”), its wholly owned subsidiary developing a multi-agentic AI platform for drug development, during a live webinar today at 12:30 p.m. Eastern. CEO Panna Sharma will lead the 45-minute session, which will cover OMAI market opportunity, customer feedback, platform capabilities, development roadmap, economics, benchmarks, potential partnerships and contribution to shareholder value.
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
AI News
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
AI News is moving the AI stack right now, and this update helps explain what changed for builders.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present Open-Medicine AI Growth Plan, Live Platform Demo in Webinar Why it matters: AI News is moving the AI stack right now, and this update helps explain what changed for builders. Source: Financialcontent https://a2zai.ai/by...
Permalink: https://a2zai.ai/bytes/ainewsbreaks-lantern-pharma-nasdaq-ltrn-to-present-open-medicine-ai-growth-plan--e9591ac2
Social card: https://a2zai.ai/bytes/ainewsbreaks-lantern-pharma-nasdaq-ltrn-to-present-open-medicine-ai-growth-plan--e9591ac2/opengraph-image